Clearing of epidermolysis bullosa acquisita with cyclosporine

Journal of the American Academy of Dermatology

Volumn 19, Issue 5, 1988, Pages 937-942

  Crow, Laura L ^a   Finkle, Jeremy P ^a   Gammon, W Ray ^a   Woodley, David T ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; AUROTHIOMALATE; AUTOANTIBODY; AZATHIOPRINE; CYCLOSPORIN A; ISOTRETINOIN; METHOTREXATE; PHENYTOIN; PREDNISONE;

AGED; CASE REPORT; EPIDERMOLYSIS BULLOSA ACQUISITA; FEMALE; HUMAN; ORAL DRUG ADMINISTRATION; PLASMAPHERESIS; PRIORITY JOURNAL;

AGED; AUTOANTIBODIES; BASEMENT MEMBRANE; CASE REPORT; CYCLOSPORINS; DRUG RESISTANCE; EPIDERMOLYSIS BULLOSA; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMAN; IMMUNOGLOBULIN G; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0023771556     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(88)70254-6     Document Type: Article

References (30)

1. Epidermolysis bullosa acquisita: report of three cases and review of all published cases
2. Epidermolysis bullosa acquisita: ultrastructural and immunological studies
3. Epidermolysis bullosa acquisita: immunofluorescence, electron microscopic and immunoelectron microscopic studies in four patients
4. Epidermolysis bullosa acquisita with electron microscopical studies
5. The immunopathology of epidermolysis bullosa acquisita
6. Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies
7. Epidermolysis bullosa acquisita: diagnosis by electron microscopy
8. Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita
9. Epidermolysis bullosa acquisita and inflammatory bowel disease
10. Evidence supporting a role for immune complex-mediated inflammation in the pathogenesis of bullous lesions of systemic lupus erythematosus
11. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods
12. Epidermolysis bullosa acquisita presenting as an inflammatory bullous disease
13. Epidermolysis bullosa acquisita—a pemphigoid-like disease
14. Unusual subepidermal bullous diseases presenting as an inflammatory bullous disease
15. Epidermolysis bullosa acquisita—a sign of cicatricial pemphigoid?
16. The spectrum of epidermolysis bullosa acquisita
17. Treatment of epidermolysis bullosa acquisita with cyclosporine [letter]
18. Dermal-epidermal separation
19. Localization of basement membrane components after dermal-epidermal junction separation
20. Differentiating anti-lamina lucida and anti-sublamina densa anti—BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin
21. Dermatologie applications of cyclosporine
22. Cyclosporin A
23. Effects of cyclosporin on bullous pemphigoid and pemphigus [letter]
24. Cyclosporine and cutaneous immune-mediated disease [letter]
25. Side effects of systemic cyclosporine in patients not undergoing transplantation
26. Action and toxicity of cyclosporine
27. Cutaneous lesions in 67 cyclosporin-treated renal transplant recipients
28. Cyclosporin A mediates immunosuppression of primary cytotoxic T-cell responses by impairing the release of interleukin 1 and interleukin 2
29. Cyclosporin A: mechanism of action
30. Mechanisms of immunosuppression by cyclosporin